Company intelligence / Profile preview
DeoBioSciences
Atlanta, Georgia, United Statesdeobiosciences.com ↗
- Ownership
- Private
- Employees
- ~3
- Development stage
- Other
01
Overview
Pre-clinical stage with positive lab results in eight advanced/metastatic cancer cell lines (skin, breast, ovarian, colorectal, lung) showing selective killing via apoptosis within 24 hours; next steps include synthesis for clinical use and animal trials.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Major biotechs and pharmas (interest in in-licensing/partnerships)Cornell University (pre-clinical testing)Ivy League scientists
Beyond the preview
Go deeper on DeoBioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DeoBioSciences.